Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19

Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis

(2020) Omer Gendelman et al.   AUTOIMMUNITY REVIEWS

The Variety of Cardiovascular Presentations of COVID-19

(2020) Justin A. Fried et al.   CIRCULATION

Treating COVID-19 with colchicine in community healthcare setting

(2020) Emanuel Della-Torre et al.   CLINICAL IMMUNOLOGY

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

(2020) Adarsh Bhimraj et al.   CLINICAL INFECTIOUS DISEASES

Colchicine may not be effective in COVID-19 infection; it may even be harmful?

(2020) Medine Cumhur Cure et al.   CLINICAL RHEUMATOLOGY

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease

(2020) Silvia Piantoni et al.   RHEUMATOLOGY

Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome

(2020) Mirko Scarsi et al.   ANNALS OF THE RHEUMATIC DISEASES

Colchicine as a possible therapeutic option in COVID-19 infection

(2020) Rafael Parra-Medina et al.   CLINICAL RHEUMATOLOGY

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019

(2020) Spyridon G. Deftereos et al.   JAMA Network Open

Colchicine treatment in community healthcare setting to prevent severe COVID-19

(2020) Emanuel Della-Torre et al.   ANNALS OF THE RHEUMATIC DISEASES

Synthesis, Biological Evaluation and Molecular Docking of Combretastatin and Colchicine Derivatives and their hCE1-Activated Prodrugs as Antiviral Agents

(2019) Michael Richter et al.   ChemMedChem

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

(2019) Jean-Claude Tardif et al.   NEW ENGLAND JOURNAL OF MEDICINE

Microtubule-mediated NF-κB activation in the TNF-α signaling pathway

(2009) Robert W. Jackman et al.   EXPERIMENTAL CELL RESEARCH